You are here

12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35209 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Type 2 Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of type 2 diabetes

- Hb1AC >7%-11% inclusive

- Male and females 18-70; females must be post-menopausal

- On a stable dose of metformin hydrochloride

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Medical history of stroke, unstable angina, heart attack within one year of
enrollment, and alcohol dependency or recent drug abuse.

- Women of childbearing potential, pregnant or nursing

- Evidence of diabetic complications with significant end-organ damage

NCT00473525
Pfizer
Completed
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Type 2 Diabetes Mellitus
NCT00424411
All Genders
35+
Years
Multiple Sites
Type 2 Diabetes Mellitus
NCT01522807
All Genders
21+
Years
Singapore,
Diabetes Mellitus, Type 2 Diabetes Mellitus, Glucose Metabolism Disorders
NCT01129258
All Genders
18+
Years
Multiple Sites
Type 2 Diabetes Mellitus
NCT00418522
All Genders
30+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now